Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...
Researchers in Edinburgh have developed a rapid stool-based test aiming to improve the diagnosis of inflammatory bowel ...
Survival is not a victory parade; it is a long-term contract with chronic illness.
A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...
inews.co.uk on MSN
Chronic UTI sufferers look forward to first new antibiotic in decades
The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is “first-in-its-class”, which means it uses a unique mechanism to treat UTIs, ...
Google's AI in Search served up false and misleading health information, according to an investigation by The Guardian.
What to do at the first symptoms of the flu, how antiviral drugs affect the body, why self-medication of the flu can be ...
Global Serological Testing Market OverviewThe global serological testing market is projected to grow at a compound annual growth rate (CAGR) of approximately 6–8% through 2027. Market expansion is ...
MedPage Today on MSN
GLP-1 Agents Showed Broader Risks, Rewards in 2025
Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...
For people with chronic illnesses, the relief and recognition of online communities can set up a toxic psychological trap ...
Some clinicians are embracing transparency in response to patients’ questions about products hyped on social media; others ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results